Prof. Dr. med. Silke Gillessen Sommer
Sequence of treatment in locally advanced and metastatic renal cell carcinoma
Fischer S, Gillessen Sommer S, Rothermundt C. Sequence of treatment in locally advanced and metastatic renal cell carcinoma. Transl Androl Urol 2015; 4:310-25.
01.06.2015Sequence of treatment in locally advanced and metastatic renal cell carcinoma
01.06.2015Transl Androl Urol 2015; 4:310-25
Fischer Stefanie, Gillessen Sommer Silke, Rothermundt Christian
Restless Legs Syndrome—An Emerging Potential Side Effect of Enzalutamide: Report of 2 Cases
Desax M, Hundsberger T, Rothermundt C, Omlin A, Gillessen Sommer S. Restless Legs Syndrome—An Emerging Potential Side Effect of Enzalutamide: Report of 2 Cases. Clin Genitourin Cancer 2015; 13:e385-6.
01.05.2015Restless Legs Syndrome—An Emerging Potential Side Effect of Enzalutamide: Report of 2 Cases
01.05.2015Clin Genitourin Cancer 2015; 13:e385-6
Desax Marie-Claire, Hundsberger Thomas, Rothermundt Christian, Omlin Aurelius, Gillessen Sommer Silke
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)
Jörger M, van Schaik R, Becker M, Hayoz S, Pollak M, Cathomas R, Winterhalder R, Gillessen Sommer S, Rothermundt C. Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09). Prostate Cancer Prostatic Dis 2015
10.03.2015Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)
10.03.2015Prostate Cancer Prostatic Dis 2015
Jörger Markus, van Schaik R H N, Becker M L, Hayoz S, Pollak M, Cathomas R, Winterhalder R, Gillessen Sommer Silke, Rothermundt Christian
Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps
Guo T, Jochum W, Jörger M, Gillessen Sommer S, Blum L, Collins B, Rosenberger G, Röst H, Wolski W, Gillet L, Koh C, Kouvonen P, Aebersold R. Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps. Nat Med 2015; 21:407-13.
02.03.2015Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps
02.03.2015Nat Med 2015; 21:407-13
Guo Tiannan, Jochum Wolfram, Jörger Markus, Gillessen Sommer Silke, Blum Lorenz C, Collins Ben C, Rosenberger George, Röst Hannes L, Wolski Witold E, Gillet Ludovic C, Koh Ching Chiek, Kouvonen Petri, Aebersold Ruedi
Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and Cabazitaxel
Omlin A, Sartor O, Rothermundt C, Cathomas R, de Bono J, Shen L, Su Z, Gillessen Sommer S. Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and Cabazitaxel. Clin Genitourin Cancer 2015
30.01.2015Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and Cabazitaxel
30.01.2015Clin Genitourin Cancer 2015
Omlin Aurelius, Sartor Oliver, Rothermundt Christian, Cathomas Richard, de Bono Johann S, Shen Liji, Su Zhen, Gillessen Sommer Silke
Management of von Hippel-Lindau Disease: An Interdisciplinary Review
Schmid S, Rothermundt C, Weber J, van Leyen K, Sulz M, Stöckli S, Krull I, Krek W, Kloos P, Heinimann K, Hader C, Greiner J, Engeler D, Brändle M, Binet F, Gillessen Sommer S, Hundsberger T. Management of von Hippel-Lindau Disease: An Interdisciplinary Review. Oncol Res Treat 2014; 37:761-771.
17.11.2014Management of von Hippel-Lindau Disease: An Interdisciplinary Review
17.11.2014Oncol Res Treat 2014; 37:761-771
Schmid Sabine, Rothermundt Christian, Weber Johannes, van Leyen Karin, Sulz Michael, Stöckli Sandro, Krull Ina, Krek Willy, Kloos Patrik, Heinimann Karl, Hader Claudia, Greiner Jeannette, Engeler Daniel, Brändle Michael, Binet Françoise-Isabelle, Gillessen Sommer Silke, Hundsberger Thomas
Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
Oldenburg J, Gillessen Sommer S, Haugnes H, Honecker F, Horwich A, Lorch A, Ondruscaron D, Rosti G, Stephenson A, Germà-Lluch J, Fossa S, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, De Wit R, Tandstad T. Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol 2014
06.11.2014Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
06.11.2014Ann Oncol 2014
Oldenburg J, Gillessen Sommer Silke, Haugnes H S, Honecker F, Horwich A, Lorch A, Ondruscaron D, Rosti G, Stephenson A, Germà-Lluch J R, Fossa S D, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, De Wit R, Tandstad T
Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone
Lorente D, de Bono J, Gillessen Sommer S, Dearnaley D, Parker C, Tunariu N, Zafeirou Z, Altavilla A, Mateo J, Perez R, Pezaro C, Ferraldeschi R, Omlin A, Attard G. Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone. Br J Cancer 2014
14.10.2014Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone
14.10.2014Br J Cancer 2014
Lorente D, de Bono J, Gillessen Sommer Silke, Dearnaley D, Parker C, Tunariu N, Zafeirou Z, Altavilla A, Mateo J, Perez R, Pezaro C, Ferraldeschi R, Omlin Aurelius, Attard G
Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe
Fizazi K, Wirth M, Wiegel T, Miller K, McDermott R, James N, Hamdy F, Gschwend J, Gillessen Sommer S, de Wit R, Culine S, Castellano D, Bellmunt J, Ahlgren G, Abrahamsson P, Tombal B. Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe. Eur Urol 2014
10.09.2014Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe
10.09.2014Eur Urol 2014
Fizazi Karim, Wirth Manfred, Wiegel Thomas, Miller Kurt, McDermott Raymond, James Nicholas, Hamdy Freddie, Gschwend Juergen E, Gillessen Sommer Silke, de Wit Ronald, Culine Stéphane, Castellano Daniel, Bellmunt Joaquim, Ahlgren Goran, Abrahamsson Per-Anders, Tombal Bertrand
Treatment sequencing in metastatic castrate-resistant prostate cancer
Sartor O, Gillessen Sommer S. Treatment sequencing in metastatic castrate-resistant prostate cancer. Asian J Androl 2014; 16:426-31.
01.05.2014Treatment sequencing in metastatic castrate-resistant prostate cancer
01.05.2014Asian J Androl 2014; 16:426-31
Sartor Oliver, Gillessen Sommer Silke
Management of bone metastases in patients with castration-resistant prostate cancer
Cathomas R, Tantawy W, Pacik D, Milecki P, Kramer G, Kacso G, Goncalves F, Gillessen Sommer S, El Ghoneimy A, Bouzid M, Bajory Z, Lesniewski-Kmak K. Management of bone metastases in patients with castration-resistant prostate cancer. Urol Int 2014; 92:377-86.
30.04.2014Management of bone metastases in patients with castration-resistant prostate cancer
30.04.2014Urol Int 2014; 92:377-86
Cathomas Richard, Tantawy Wahid, Pacik Dalibor, Milecki Piotr, Kramer Gero, Kacso Gabriel, Goncalves Frederico, Gillessen Sommer Silke, El Ghoneimy Ahmed, Bouzid Mounira, Bajory Zoltan, Lesniewski-Kmak Krzystof
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
Fitzpatrick J, Fosså S, Gillessen Sommer S, Kellokumpu-Lehtinen P, Lecouvet F, Oudard S, de Reijke T, Robson C, De Santis M, Seruga B, Finn S, Efstathiou E, Bellmunt J, Fizazi K, Heidenreich A, Sternberg C, Tombal B, Alcaraz A, Bahl A, Bracarda S, Di Lorenzo G, de Wit R. Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel. Eur J Cancer 2014; 50:1617-27.
03.04.2014Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
03.04.2014Eur J Cancer 2014; 50:1617-27
Fitzpatrick John M, Fosså Sophie, Gillessen Sommer Silke, Kellokumpu-Lehtinen Pirkko-Liisa, Lecouvet Frédéric E, Oudard Stephane, de Reijke Theo M, Robson Craig N, De Santis Maria, Seruga Bostjan, Finn Stephen P, Efstathiou Eleni, Bellmunt Joaquim, Fizazi Karim, Heidenreich Axel, Sternberg Cora N, Tombal Bertrand, Alcaraz Antonio, Bahl Amit, Bracarda Sergio, Di Lorenzo Giuseppe, de Wit Ronald
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer
de Bono J, Scranton J, Wang T, Hudes G, Gillessen Sommer S, Fong P, Sandhu S, Aparicio L, Saad F, Petrylak D, Pandha H, Piulats J, Pollak M. Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer. Clin Cancer Res 2014; 20:1925-34.
17.02.2014Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer
17.02.2014Clin Cancer Res 2014; 20:1925-34
de Bono Johann S, Scranton Judith, Wang Tao, Hudes Gary R, Gillessen Sommer Silke, Fong Peter, Sandhu Shahneen K, Aparicio Luis Miguel A, Saad Fred, Petrylak Daniel P, Pandha Hardev S, Piulats Josep M, Pollak Michael N
Abiraterone--what is wrong with the adrenal glands?
Schmid S, Fornaro J, Rothermundt C, Omlin A, Brändle M, Rupp N, Gillessen Sommer S. Abiraterone--what is wrong with the adrenal glands?. Clin Genitourin Cancer 2014; 12:e133-7.
04.02.2014Abiraterone--what is wrong with the adrenal glands?
04.02.2014Clin Genitourin Cancer 2014; 12:e133-7
Schmid Sabine, Fornaro Jürgen, Rothermundt Christian, Omlin Aurelius, Brändle Michael, Rupp Niels J, Gillessen Sommer Silke
Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy
Omlin A, Pezaro C, Gillessen Sommer S. Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy. Ther Adv Urol 2014; 6:3-14.
01.02.2014Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy
01.02.2014Ther Adv Urol 2014; 6:3-14
Omlin Aurelius, Pezaro Carmel, Gillessen Sommer Silke
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
Rothermundt C, Cathomas R, Rüschoff J, Schiess R, Endt K, Lui L, Pollak M, Bärtschi D, Strebel R, Winterhalder R, Templeton A, Hayoz S, Gillessen Sommer S. Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09). Eur Urol 2014; 66:468-74.
04.01.2014Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
04.01.2014Eur Urol 2014; 66:468-74
Rothermundt Christian, Cathomas Richard, Rüschoff Jan H, Schiess Ralph, Endt Kathrin, Lui Lillianne, Pollak Michael, Bärtschi Daniela, Strebel Räto T, Winterhalder Ralph, Templeton Arnoud, Hayoz Stefanie, Gillessen Sommer Silke
Maligne spinale Kompression
Omlin A, Stienen M, Brügge D, Fretz C, Gillessen Sommer S, Hundsberger T. Maligne spinale Kompression - Prävention, Erkennung und «State of the Art»-Behandlung. SMF 2014; 14:820-825.
01.01.2014Maligne spinale Kompression
01.01.2014SMF 2014; 14:820-825
Omlin Aurelius, Stienen Martin N., Brügge Detlef, Fretz Christian, Gillessen Sommer Silke, Hundsberger Thomas
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
Jörger M, Huitema A, Koeberle D, Rosing H, Beijnen J, Hitz F, Cerny T, Schellens J, Gillessen Sommer S. Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction. Cancer Chemother Pharmacol 2013; 73:113-24.
29.10.2013Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
29.10.2013Cancer Chemother Pharmacol 2013; 73:113-24
Jörger Markus, Huitema A D R, Koeberle D, Rosing H, Beijnen J H, Hitz Felicitas, Cerny Thomas, Schellens J H M, Gillessen Sommer Silke
Optimizing treatment of seminoma stage IIA/B step by step
Papachristofilou A, Cathomas R, Bedke J, Souchon R, Kolb C, Gillessen Sommer S. Optimizing treatment of seminoma stage IIA/B step by step. Ann Oncol 2013; 24:2463.
17.07.2013Optimizing treatment of seminoma stage IIA/B step by step
17.07.2013Ann Oncol 2013; 24:2463
Papachristofilou A, Cathomas R, Bedke J, Souchon R, Kolb C, Gillessen Sommer Silke
Management of elderly patients with advanced non-small cell lung cancer: a single-center experience
Früh M, Besrour H, Gillessen Sommer S, Jörger M, Hitz F, Savidan A, Cerny T, Ess S. Management of elderly patients with advanced non-small cell lung cancer: a single-center experience. Chemotherapy 2013; 59:42-50.
02.07.2013Management of elderly patients with advanced non-small cell lung cancer: a single-center experience
02.07.2013Chemotherapy 2013; 59:42-50
Früh Martin, Besrour H, Gillessen Sommer Silke, Jörger Markus, Hitz Felicitas, Savidan A, Cerny Thomas, Ess S